Loading...
Anti-AURKA Recombinant Antibody Products
Loading...Anti-AURKA Products
- Recombinant Human Anti-AURKA Soluble TCR (scTCR-008CQ-S(P)) (scTCR-008CQ-S(P))
-
- Species Reactivity: Human
- Epitope: YLILEYAPL
- MHC: HLA-A*0201
- Rabbit Anti-AURKA Recombinant Antibody (clone CBACN-055) (MRO-0145-CN)
-
- Species Reactivity: Human, Mouse
- Type: Rabbit IgG
- Application: WB, IF, FC
-
- Species Reactivity: Human, Rat, Monkey
- Type: Mouse IgG
- Application: WB, IHC, ELISA
-
- Species Reactivity: Human, Monkey
- Type: Mouse IgG
- Application: WB, ICC
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: ELISA, IF
-
- Species Reactivity: Human
- Epitope: YLILEYAPL
- MHC: HLA-A*0201
- Recombinant Human Anti-AURKA Soluble TCR (C-Cys) (VS-0622-YF2716) (VS-0622-YF2716)
-
- Species Reactivity: Human
- Epitope: YLILEYAPL
- MHC: HLA-A*0201
- Recombinant Human Anti-AURKA Soluble TCR (KIH) (VS-0622-YF5424) (VS-0622-YF5424)
-
- Species Reactivity: Human
- Epitope: YLILEYAPL
- MHC: HLA-A*0201
-
- Species Reactivity: Human, Mouse
- Type: Rabbit IgG
- Application: WB, ICC, IF, FC
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB, ICC, FC
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB, IHC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: WB, ICC, IHC, FC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, IHC
- Recombinant Mouse Anti-AURKA Antibody (VS-0923-FY22) (VS-0923-FY22)
-
- Species Reactivity: Human
- Type: Mouse IgG2a
- Application: ELISA, WB
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG3
- Application: WB, ELISA, IF, IHC
- Mouse Anti-AURKA Recombinant Antibody (clone 46D2) (MOB-0869MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: ELISA, IF, IHC-Fr, IHC-P, IP, WB
- Mouse Anti-NHP AURKA Recombinant Antibody (clone 1F8) (VS-1024-XY42)
-
- Species Reactivity: Human, Non-human primate, Rat
- Type: Mouse IgG1
- Application: WB, FC, ELISA
-
- Derivation: Mouse
- Species Reactivity: Human, Mouse
- Type: Mouse IgG1
- Application: WB, IHC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: WB, IHC, ICC, FCM
-
- Derivation: Mouse
- Species Reactivity: Human, Rat, Monkey
- Type: Mouse IgG
- Application: WB, IF, ICC, FCM, ELISA
-
- Derivation: Mouse
- Species Reactivity: Human, Rat, Monkey
- Type: Mouse IgG
- Application: WB, IHC-p, IF, ELISA
- Anti-AURKA Immunohistochemistry Kit (VS-0325-XY214)
-
- Species Reactivity: Human, Mouse, Rat
- Target: AURKA
- Application: IHC
-
- Derivation: Phage display library screening
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: IHC-P, IP, WB
-
- Species Reactivity: Human, Mouse, Rat
- Type: Rabbit IgG
- Application: WB, ICC, IF, IHC-P, FC
- Anti-Mouse AURKA Immunohistochemistry Kit (VS-0525-XY659)
-
- Species Reactivity: Human, Mouse
- Target: AURKA
- Application: IHC
- Anti-Human AURKA Immunohistochemistry Kit (VS-0525-XY658)
-
- Species Reactivity: Human
- Target: AURKA
- Application: IHC
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs is a pioneer in the oncology and cell cycle space, providing world-class anti-Aurora Kinase A (AURKA) recombinant antibodies for functional work. As an enzyme required for cell division, and a validated therapeutic target in cancer, AURKA is a master regulator of mitotic entry and spindle assembly. Our highly specific and validated antibodies are vital reagents to investigate mitosis, aneuploidy, and the response to emerging AURKA inhibitors.
AURKA: A Master Regulator of Mitosis and a Key Cancer Target
AURKA (Aurora Kinase A) is a serine/threonine kinase that orchestrates several checkpoints throughout mitosis. It is involved in centrosome maturation, mitotic spindle assembly, and chromosome segregation. Aurora Kinase A is overexpressed/amplified in the majority of human cancers, including breast, ovarian, and colon cancers. It has been shown to drive chromosomal instability and aneuploidy, both of which are drivers of oncogenesis, and to also promote tumor progression and therapy resistance. As such, AURKA is a prime target in modern drug development for cancer therapeutics.
Alternative Names
Aurora Kinase A; Protein Phosphatase 1, Regulatory Subunit 47; Serine/Threonine-Protein Kinase Aurora-A; Serine/Threonine-Protein Kinase 6; Breast Tumor-Amplified Kinase; Aurora/IPL1-Related Kinase 1; Aurora 2; STK15; STK6; ARK1; AURA; BTAK; AIK; Serine/Threonine Protein Kinase 15; Serine/Threonine-Protein Kinase 15; AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6; Aurora kinase A; Aurora 2; Aurora/IPL1-related kinase 1; ARK-1; Aurora-related kinase 1; hARK1; Breast tumor-amplified kinase; Serine/threonine-protein kinase 15; Serine/threonin
Background
The protein encoded by this gene is a cell cycle-regulated kinase that appears to be involved in microtubule formation and/or stabilization at the spindle pole during chromosome segregation. The encoded protein is found at the centrosome in interphase cells and at the spindle poles in mitosis. This gene may play a role in tumor development and progression. A processed pseudogene of this gene has been found on chromosome 1, and an unprocessed pseudogene has been found on chromosome 10. Multiple transcript variants encoding the same protein have been found for this gene.
Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins
Intracellular
Cell type enhanced (Spermatocytes, Erythroid cells, Extravillous trophoblasts, granulocytes)
Low immune cell specificity
Low cell line specificity
Interacts with FBXL7 (By similarity). Interacts with CPEB1, JTB, TACC1, TPX2, PPP2CA, as well as with the protein phosphatase type 1 (PP1) isoforms PPP1CA, PPP1CB and PPP1CC. Interacts also with its substrates ARHGEF2, BORA, KIF2A, PARD3, and p53/TP53. Interaction with BORA promotes phosphorylation of PLK1. Interacts with PIFO. Interacts with GADD45A, competing with its oligomerization. Interacts (via C-terminus) with AUNIP (via C-terminus). Identified in a complex with AUNIP and NIN. Interacts with FRY; this interaction facilitates AURKA-mediated PLK1 phosphorylation. Interacts with SIRT2 (PubMed:17726514, PubMed:22014574). Interacts with MYCN; interaction is phospho-independent and triggers AURKA activation; AURKA competes with FBXW7 for binding to unphosphorylated MYCN but not for binding to phosphorylated MYCN (PubMed:27837025). Interacts with HNRNPU (PubMed:21242313, PubMed:25986610). Interacts with AAAS (PubMed:26246606). Interacts with KLHL18 and CUL3 (PubMed:23213400). Interacts with FOXP1 (PubMed:28218735).
Kinase, Serine/threonine-protein kinase, Transferase
Anti-AURKA rAb Products
Creative Biolabs' anti-AURKA recombinant antibodies are designed with superior specificity and functionality in mind. Each batch of antibodies is validated to detect the AURKA enzyme in cell lysates and tumor tissue, allowing for accurate assessment of its expression and phosphorylation state. Optimized for Western Blot, IHC, and immunofluorescence applications, these rAbs are designed with the reliability your cancer research demands.
Table 1. Featured anti-AURKA recombinant antibody products at Creative Biolabs.
| Cat. No. | Product Name | Target Species | Host Species | Applications |
| ZG-0311F | Mouse Anti-AURKA Recombinant Antibody (ZG-0311F) | Human, Rat, Monkey | Mouse IgG | WB, IHC, ELISA |
| ZG-0318F | Mouse Anti-AURKA Recombinant Antibody (ZG-0318F) | Human, Monkey | Mouse IgG | WB, IHC |
| ZG-0562J | Rabbit Anti-AURKA Recombinant Antibody (clone 1H8) | Human | Rabbit IgG | ELISA, IF |
Creative Quality Control
At Creative Biolabs, we are committed to supporting the needs of the innovative oncology and cell cycle researcher. Our anti-AURKA recombinant antibodies are produced under a robust quality control program. Each batch is thoroughly tested for purity, specificity to other Aurora kinases (B and C), and performance to ensure you receive the highest quality reagent.
Fig.1 IHC analysis of anti-AURKA antibody
(Cat# ZG-0311F, Creative Biolabs).
Fig.2 ELISA analysis of anti-AURKA antibody
(Cat# ZG-0311F, Creative Biolabs).
Fig.3 IF analysis of anti-AURKA antibody
(Cat# ZG-0562J, Creative Biolabs).
Customer Reviews
Mouse Anti-AURKA Recombinant Antibody (ZG-0311F)
Rabbit Anti-AURKA Recombinant Antibody (clone 1H8)
rAb Production
Creative Biolabs uses advanced platforms for the production of recombinant antibodies to help move novel cancer therapeutics forward. Our anti-AURKA recombinant antibodies are produced in systems specifically engineered to ensure they are highly specific to the native kinase, which means a more biologically active product for your research.
Featured Anti-AURKA Recombinant Antibody Production Platforms
Fig.4 Milligram-scale anti-AURKA recombinant antibody production.
Fig.5 Gram-scale anti-AURKA recombinant antibody production.
rAb Modalities
Creative Biolabs is here to deliver innovative solutions for oncology researchers. Our anti-AURKA recombinant antibodies are available in a wide range of customizable modalities, including phospho-specific antibodies for monitoring enzyme activity, so researchers across the globe can study this important mitotic kinase.
Fig.6 Full-length anti-AURKA recombinant antibody production and modalities.
Target cell division in cancer with Creative Biolabs' high-quality anti-AURKA recombinant antibodies. Our catalog is designed to meet the needs of today's researcher, providing the specificity and functional activity required to study this important oncogenic kinase. Rely on our experience to provide a strong foundation for next-generation cancer therapeutics. Connect with our scientific team today.


